The Pathology and Tissue Core of the Johns Hopkins Lung SPORE program was initiated approximately 14 years ago. The Core activities have evolved over this time period. While the initial emphasis of the Core was to collect frozen tissue samples, services added in response to evolving need of the SPORE include tissue microdissection, collection of specialized samples (lymph nodes, bronchiolaveolar lavage, sputum), expanded data collection and management services, establishing tissue microarrays (TMAs), and pathology consultation for use of human specimens as well as animal models. In addition, the Core has supported the continuous development and refinement of a relational database that provides comprehensive clinical data for all lung cancer patients at the institution in addition to annotation for the pathology specimens in the Core. All of the resources of this Core are leveraged beyond our own SPORE program, as we continue to have active collaborative efforts with investigators at other institutions, including investigators in other SPORE programs. In the past two years, investigators in our program have recognized a need for laboratory models that resemble human lung cancer more closely that do the standard cultured lung cancer cell lines. This prompted the development of a new resource in the Core for establishing transplantable xenografts from clinical samples of human lung cancers. We expect that this resource will contribute significantly to work of investigators throughout the lung cancer research community in coming years, as well as to the projects of our SPORE. Thus, the basic functions of this Core can be summarized as follows: ? Collect, store, and distribute tissues and other biological samples relevant to the study of lung cancer. ? Collect, maintain, and provide access to clinical and pathological data related to all lung cancer patients treated at Johns Hopkins, including those related to these specimens. ? Develop newtransplantable xenograft models of lung cancer from clinical samples ? Provide expert pathologist consultation for molecular studies of human lung cancer and for studies involving rodent models of lung cancer. Relevance to Public Health: This Core provides valuable resources to link laboratory studies to clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA058184-18
Application #
8403069
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
18
Fiscal Year
2013
Total Cost
$271,614
Indirect Cost
$90,004
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zhong, Yi; Macgregor-Das, Anne M; Saunders, Tyler et al. (2016) Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer. Clin Cancer Res :
Chiappinelli, Katherine B; Zahnow, Cynthia A; Ahuja, Nita et al. (2016) Combining Epigenetic and Immunotherapy to Combat Cancer. Cancer Res 76:1683-9
Sussan, Thomas E; Gajghate, Sachin; Thimmulappa, Rajesh K et al. (2015) Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 10:e0116861
Chiappinelli, Katherine B; Strissel, Pamela L; Desrichard, Alexis et al. (2015) Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell 162:974-86
Belinsky, Steven A (2015) Unmasking the lung cancer epigenome. Annu Rev Physiol 77:453-74
Vendetti, Frank P; Topper, Michael; Huang, Peng et al. (2015) Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget 6:56-70
Kim, Jung-Hyun; Thimmulappa, Rajesh K; Kumar, Vineet et al. (2014) NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation. J Clin Invest 124:730-41
Gardner, Eric E; Connis, Nick; Poirier, John T et al. (2014) Rapamycin rescues ABT-737 efficacy in small cell lung cancer. Cancer Res 74:2846-56
Ahuja, Nita; Easwaran, Hariharan; Baylin, Stephen B (2014) Harnessing the potential of epigenetic therapy to target solid tumors. J Clin Invest 124:56-63
Izumchenko, Evgeny; Chang, Xiaofei; Michailidi, Christina et al. (2014) The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors. Cancer Res 74:3995-4005

Showing the most recent 10 out of 252 publications